These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9104119)
41. Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy. Fischer PA J Neural Transm Suppl; 1995; 46():381-9. PubMed ID: 8821073 [TBL] [Abstract][Full Text] [Related]
43. New concepts in the treatment of Parkinson's disease. Ahlskog JE; Wilkinson JM Am Fam Physician; 1990 Feb; 41(2):574-84. PubMed ID: 1967895 [TBL] [Abstract][Full Text] [Related]
44. Effective strategies in the management of Parkinson's disease. Wills AJ Hosp Med; 1998 Apr; 59(4):287-90. PubMed ID: 9722367 [TBL] [Abstract][Full Text] [Related]
45. Drug therapy for Parkinson's disease in the elderly. Robertson DR; George CF Br Med Bull; 1990 Jan; 46(1):124-46. PubMed ID: 2105818 [TBL] [Abstract][Full Text] [Related]
46. Treatment of Parkinson's disease with agents other than levodopa and dopamine agonists: controversies and new approaches. Lang AE Can J Neurol Sci; 1984 Feb; 11(1 Suppl):210-20. PubMed ID: 6143611 [TBL] [Abstract][Full Text] [Related]
48. Drug therapy for Parkinson's disease. Charles PD; Davis TL South Med J; 1996 Sep; 89(9):851-6. PubMed ID: 8790306 [TBL] [Abstract][Full Text] [Related]
53. [Some approaches to therapy of Parkinson's disease]. Gregory R Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(5):56-7. PubMed ID: 11505920 [No Abstract] [Full Text] [Related]
54. Pharmacogenetics of antiparkinsonian drug treatment: a systematic review. Arbouw ME; van Vugt JP; Egberts TC; Guchelaar HJ Pharmacogenomics; 2007 Feb; 8(2):159-76. PubMed ID: 17286539 [TBL] [Abstract][Full Text] [Related]
55. The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy. Cheong SL; Federico S; Spalluto G; Klotz KN; Pastorin G Drug Discov Today; 2019 Sep; 24(9):1769-1783. PubMed ID: 31102728 [TBL] [Abstract][Full Text] [Related]
56. Developments in the treatment of Parkinson's disease. Drug Ther Bull; 1999 May; 37(5):36-40. PubMed ID: 10563057 [TBL] [Abstract][Full Text] [Related]
58. ABCB1: is there a role in the drug treatment of Parkinson's disease? Müller T Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):127-129. PubMed ID: 29224383 [No Abstract] [Full Text] [Related]
59. Anxiety: An ignored aspect of Parkinson's disease lacking attention. Khatri DK; Choudhary M; Sood A; Singh SB Biomed Pharmacother; 2020 Nov; 131():110776. PubMed ID: 33152935 [TBL] [Abstract][Full Text] [Related]
60. New lessons from old drugs: amantadine and Parkinson's disease. Goetz CG Neurology; 1998 May; 50(5):1211-2. PubMed ID: 9595964 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]